Nasdaq, Inc. is a global financial technology company and exchange operator best known for the Nasdaq Stock Market in the United States. It operates multiple equity, options, and derivatives markets in the U.S. and Europe (including Nasdaq Nordic and Baltic), and provides clearing and market services, listing services, indexes such as the Nasdaq‑100, and market data and analytics. Nasdaq also supplies market infrastructure technology and surveillance systems to exchanges and financial institutions worldwide, and offers anti–financial crime and compliance solutions. The company’s roots trace to the launch of the Nasdaq market in 1971, originally known as the National Association of Securities Dealers Automated Quotations.
For the chemicals and materials sector, Nasdaq provides the venues and technology for capital raising, trading, and valuation transparency for numerous public issuers across the value chain. Its data, indexes, and analytics are widely used by investors and corporates to track sector performance, manage risk, and benchmark strategy.
Also known as National Association of Securities Dealers Automated Quotations and Nasdaq Stock Market.
Existing partner shifts collaboration from industrial projects to capital participation, advancing plans for next‑generation battery module manufacturing in Japan for heavy‑duty electrification.
Adds FB102, a first‑in‑class anti‑CD122 with clinical proof‑of‑concept in vitiligo and celiac disease; $77 per‑share tender offer completed and merger closed.
Record date June 15; distribution expected June 29 with one new share per two held; new Nasdaq ticker for Aerospace; concurrent 1-for-2 reverse split reduces outstanding and authorized shares.
IPO of 40M H‑shares in Hong Kong raised ~$75M and implied ~US$750M market cap; JV reports annual revenue of roughly $77–87M and targets waste‑derived ethanol‑to‑SAF.
Novo Nordisk acquired Akero for $4.7B, with a $0.5B contingent on EFX approval. Akero is now a subsidiary, and its stock is delisted from Nasdaq.
